Download

Differentially Variable and differentially Methylated CpGs (DVMCs)

DVMCs.txt.gz (409M)

Differentially methylated genes

DMGs.txt.gz (9.8M)

CpGs or genes whose methylation are associated with survival

GeneMethSurvival.txt.gz (8.6M)

CpGMethSurvival.txt.gz (70.2M)

Pearson and Spearman correlation between methylation of gene promoter and gene expression (FPKM)

TCGA_Meth_FPKM_Correlation.txt.gz (8.6M)

Pathway-meQTL for 24 cancer types of TCGA

BLCA (Bladder Urothelial Carcinoma) (740.35 M)

BRCA (Breast invasive carcinoma) (383.0 M)

CESC (Cervical squamous cell carcinoma and endocervical adenocarcinoma) (207.37 M)

CHOL (Cholangiocarcinoma) (394.03 M)

COAD (Colon adenocarcinoma) (623.75 M)

ESCA (Esophageal carcinoma ) (640.83 M)

GBM (Glioblastoma multiforme) (379.81 M)

HNSC (Head and Neck squamous cell carcinoma) (155.23 M)

KICH (Kidney Chromophobe) (111.41 M)

KIRC (Kidney renal clear cell carcinoma) (248.93 M)

KIRP (Kidney renal papillary cell carcinoma) (354.72 M)

LIHC (Liver hepatocellular carcinoma) (721.59 M)

LUAD (Lung adenocarcinoma) (375.44 M)

LUSC (Lung squamous cell carcinoma) (433.8 M)

PAAD (Pancreatic adenocarcinoma) (818.61 M)

PCPG (Pheochromocytoma and Paraganglioma) (272.73 M)

PRAD (Prostate adenocarcinoma) (736.02 M)

READ (Rectum adenocarcinoma) (353.91 M)

SARC (Sarcoma) (395.21 M)

SKCM (Skin Cutaneous Melanoma) (336.73 M)

STAD (Stomach adenocarcinoma) (770.23 M)

THCA (Thyroid carcinoma) (195.83 M)

THYM (Thymoma) (1.29 G)

UCEC (Uterine Corpus Endometrial Carcinoma) (20.09 M)

Cancer hallmark associated pathway-meQTL for 24 cancer types of TCGA

BLCA (Bladder Urothelial Carcinoma) (21.43 M)

BRCA (Breast invasive carcinoma) (13.07 M)

CESC (Cervical squamous cell carcinoma and endocervical adenocarcinoma) (7.44 M)

CHOL (Cholangiocarcinoma) (14.61 M)

COAD (Colon adenocarcinoma) (22.0 M)

ESCA (Esophageal carcinoma ) (16.0 M)

GBM (Glioblastoma multiforme) (13.62 M)

HNSC (Head and Neck squamous cell carcinoma) (5.05 M)

KICH (Kidney Chromophobe) (4.51 M)

KIRC (Kidney renal clear cell carcinoma) (6.88 M)

KIRP (Kidney renal papillary cell carcinoma) (10.3 M)

LIHC (Liver hepatocellular carcinoma) (25.57 M)

LUAD (Lung adenocarcinoma) (15.09 M)

LUSC (Lung squamous cell carcinoma) (15.86 M)

PAAD (Pancreatic adenocarcinoma) (27.15 M)

PCPG (Pheochromocytoma and Paraganglioma) (10.57 M)

PRAD (Prostate adenocarcinoma) (21.3 M)

READ (Rectum adenocarcinoma) (12.74 M)

SARC (Sarcoma) (10.23 M)

SKCM (Skin Cutaneous Melanoma) (13.86 M)

STAD (Stomach adenocarcinoma) (31.96 M)

THCA (Thyroid carcinoma) (6.15 M)

THYM (Thymoma) (42.79 M)

UCEC (Uterine Corpus Endometrial Carcinoma) (0.7 M)

emQTL for 28 cancer types of TCGA

ACC (Adrenocortical carcinoma) (13.42 M)

BLCA (Bladder Urothelial Carcinoma) (3.65 G)

BRCA (Breast invasive carcinoma) (4.33 G)

CESC (Cervical squamous cell carcinoma and endocervical adenocarcinoma) (518.62 M)

CHOL (Cholangiocarcinoma) (36.28 M)

COAD (Colon adenocarcinoma) (1.78 G)

ESCA (Esophageal carcinoma ) (781.82 M)

GBM (Glioblastoma multiforme) (13.38 M)

HNSC (Head and Neck squamous cell carcinoma) (1.01 G)

KICH (Kidney Chromophobe) (29.92 M)

KIRC (Kidney renal clear cell carcinoma) (1.48 G)

KIRP (Kidney renal papillary cell carcinoma) (1.55 G)

LAML (Acute Myeloid Leukemia) (22.88 M)

LGG (Brain Lower Grade Glioma) (7.67 G)

LIHC (Liver hepatocellular carcinoma) (2.91 G)

LUAD (Lung adenocarcinoma) (2.27 G)

LUSC (Lung squamous cell carcinoma) (1.76 G)

OV (Ovarian serous cystadenocarcinoma) (0.01 M)

PAAD (Pancreatic adenocarcinoma) (1.18 G)

PCPG (Pheochromocytoma and Paraganglioma) (293.76 M)

PRAD (Prostate adenocarcinoma) (6.52 G)

READ (Rectum adenocarcinoma) (16.56 M)

SARC (Sarcoma) (686.15 M)

SKCM (Skin Cutaneous Melanoma) (2.3 G)

STAD (Stomach adenocarcinoma) (2.09 G)

THCA (Thyroid carcinoma) (2.6 G)

THYM (Thymoma) (3.54 G)

UCEC (Uterine Corpus Endometrial Carcinoma) (181.12 M)